Disclosed positions

Estimated from their latest filings — positions may have changed since

$4.92M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ACRVAcrivon Therapeutics, Inc.	2,645,389	$1.86	$4.92M	100%	2026-05-18

ACRV

Acrivon Therapeutics, Inc.

$4.92M

2,645,389 sh

Activity

Open-market buy & sell volume

BuySell

Total +$82.1K bought

Most bought

ACRV

$82.1K

All filings on record

Every Form 4 transaction we track for this filer

all 14buys 1sells 0

Stock	Transaction	Date	~6mo later
ACRVAcrivon Therapeutics, Inc.	Grant — · 72,706 sh	2026-05-18	—
ACRVAcrivon Therapeutics, Inc.	Grant — · 180,095 sh	2026-05-18	—
ACRVAcrivon Therapeutics, Inc.	Tax $940.80 · 490 sh	2026-05-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $2.4K · 1,253 sh	2026-05-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $21.8K · 14,265 sh	2026-02-21	—
ACRVAcrivon Therapeutics, Inc.	Tax $943.77 · 579 sh	2026-02-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $2.1K · 1,302 sh	2026-02-14	—
ACRVAcrivon Therapeutics, Inc.	Buy $82.1K · 49,000 sh	2026-01-14	in progress
ACRVAcrivon Therapeutics, Inc.	Tax $45.8K · 19,904 sh	2025-11-21	—
ACRVAcrivon Therapeutics, Inc.	Tax $1.1K · 490 sh	2025-11-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $133.9K · 59,765 sh	2025-11-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $26.3K · 19,905 sh	2025-08-21	—
ACRVAcrivon Therapeutics, Inc.	Tax $681.10 · 490 sh	2025-08-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $83.1K · 59,766 sh	2025-08-14	—

ACRVGrant

2026-05-18 · Acrivon Therapeutics, Inc.

72,706

—

ACRVGrant

2026-05-18 · Acrivon Therapeutics, Inc.

180,095

—

ACRVTax

2026-05-14 · Acrivon Therapeutics, Inc.

$940.80

—

ACRVTax

2026-05-14 · Acrivon Therapeutics, Inc.

$2.4K

—

ACRVTax

2026-02-21 · Acrivon Therapeutics, Inc.

$21.8K

—

ACRVTax

2026-02-14 · Acrivon Therapeutics, Inc.

$943.77

—

ACRVTax

2026-02-14 · Acrivon Therapeutics, Inc.

$2.1K

—

ACRVBuy

2026-01-14 · Acrivon Therapeutics, Inc.

$82.1K

in progress

ACRVTax

2025-11-21 · Acrivon Therapeutics, Inc.

$45.8K

—

ACRVTax

2025-11-14 · Acrivon Therapeutics, Inc.

$1.1K

—

ACRVTax

2025-11-14 · Acrivon Therapeutics, Inc.

$133.9K

—

ACRVTax

2025-08-21 · Acrivon Therapeutics, Inc.

$26.3K

—

ACRVTax

2025-08-14 · Acrivon Therapeutics, Inc.

$681.10

—

ACRVTax

2025-08-14 · Acrivon Therapeutics, Inc.

$83.1K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.